Abstract 6557: Combined PARP inhibition and immune checkpoint blockade elicit differentially improved survival in BRCA1, BRCA2 vs CHEK2, ATM deficient breast cancer by promoting an anti-tumor immune response through tertiary lymphoid structure formation
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Sibapriya Chaudhuri, Alberto Emata, Scott Thomas, Pamela N. Munster
Institution: University of California, San Francisco
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148878113
Cites:
Cited by:
Related to: